Boston Partners’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-621,984
Closed -$8.7M 740
2023
Q3
$8.7M Sell
621,984
-1,035,879
-62% -$15.7M 0.01% 376
2023
Q2
$23.4M Sell
1,657,863
-67,408
-4% -$917K 0.03% 297
2023
Q1
$27.4M Buy
1,725,271
+49,841
+3% +$881K 0.04% 279
2022
Q4
$26M Buy
+1,675,430
New +$29.2M 0.04% 276
2022
Q1
Sell
-21,725
Closed -$889K 713
2021
Q4
$889K Buy
21,725
+5,813
+37% +$242K ﹤0.01% 553
2021
Q3
$674K Sell
15,912
-6,400
-29% -$316K ﹤0.01% 577
2021
Q2
$1.18M Buy
+22,312
New +$1.11M ﹤0.01% 518

Other funds holding HLF

Boston Partners's HLF Position: Q4 2023 in Review

Boston Partners sold out of Herbalife (HLF) in Q4 2023, closing a stake of 621,984 shares — an estimated $8.7M sold.

Boston Partners first reported a position in HLF in Q2 2021 and held it in 7 quarters. The position peaked at $27.4M in Q1 2023. 197 funds tracked by Wall St. Rank hold HLF as of Q4 2023.

  • Boston Partners reported no remaining Herbalife position as of Q4 2023 after selling out during the quarter.
  • Boston Partners sold 621,984 Herbalife shares in Q4 2023, an estimated $8.7M.
  • Boston Partners first reported a position in Herbalife in Q2 2021 and held it in 7 quarters.
  • Boston Partners's Herbalife position peaked at $27.4M in Q1 2023.
  • 197 funds tracked by Wall St. Rank held Herbalife as of Q4 2023.

Based on Boston Partners's 13F filing for Q4 2023, filed 7 Feb 2024.